ImplEMenting a nurse-coordinated, INtegrated, shared-care model involving specialists and general practitioners in breast cancer post-treatmENT follow-up: a Phase II randomised controlled trial (The EMINENT Trial)

Professor Raymond Chan0 sites63 target enrollmentNovember 19, 2019

Overview

No summary available.

Registry

who.int

Start Date

November 19, 2019

End Date

April 30, 2022

Last Updated

3 years ago

Study Type

Interventional

Sex

All

Sponsor

Professor Raymond Chan

•Patients who
•\- are treated at the Princess Alexandra Hospital
•\- following criteria will be considered for inclusion in the study:
•\- are from 4 weeks pre\-completion up to 18 months after completion of adjuvant treatment for early stage breast cancer patients (including Ductal Carcinoma In\-Situ (DCIS) and locally advanced) at the Princess Alexandra Hospital; OR within 4 weeks to 18 months post\-surgery if they are not scheduled for any further adjuvant therapy
•\- have received a diagnosis of curable early breast cancer (i.e. no distant metastases);
•\- are able to speak and read English;
•\- are at least 18 years of age;
•\- are ambulatory patient at the time of recruitment;
•\- have an Eastern Cooperative Oncology Group performance status 0 or 1;
•\- are able to nominate a GP to be involved in their follow\-up; and

•\- the presence of severe mental, cognitive or physical conditions that would limit the patient’s ability to participate.
•\- breast cancer recurrence
•\- presence of distant metastases